Electronic informed consent (e-consent) for eyegene

Ended Purchase Order Awarded Last action

Contract number
HHSN263201700368A
Awardee
Awarding agency
Obligated
$405,831

Award facts

Opportunity
Contract value 100% obligated
$405,831.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00004 $82,291
Supplemental Agreement for work within scope 3 $62,640
Exercise an Option 2 $68,500
Funding Only Action 1 $25,600
Original award $166,800

About this award

The Department of Health and Human Services National Institutes of Health awarded a $405,831.00 firm fixed price purchase order to Parallel 6, Inc., a San Diego, California-based provider of clinical trial software solutions and services. The contract, which had no set-aside designation, is for Parallel 6 to provide its Clinical6 electronic consent software to support the eyeGENE genetic research initiative from August 2020 through July 2023. Parallel 6 has also partnered as a subcontractor with Peraton Enterprise Solutions LLC to provide software support and renewal services for this contract.

Quick answers

Who was awarded contract HHSN263201700368A?

HHSN263201700368A was awarded to Parallel 6, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on July 31, 2017.

How much is contract HHSN263201700368A worth?

The government has obligated $405,831 on HHSN263201700368A.

Was contract HHSN263201700368A competed?

The extent of competition for HHSN263201700368A was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award